Biology Reference
In-Depth Information
mutations: truncated EPO receptors are most frequently associated with primary familial and
congenital polycythemias.
Blood
90: 2057-2061
91 Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M, Azegami T, Kishi K,
Takahashi M, Utsumi J et al. (1997) Primary familial polycythaemia associated with a novel point
mutation in the erythropoietin receptor.
Br J Haematol
99: 222-227
92 Kralovics R, Sokol L, Prchal JT (1998) Absence of polycythemia in a child with a unique ery-
thropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
J Clin
Invest
102: 124-129
93 Percy MJ, McMullin MF, Roques AW, Westwood NB, Acharya J, Hughes AE, Lappin TR,
Pearson TC (1998) Erythrocytosis due to a mutation in the erythropoietin receptor gene.
Br J
Haematol
100: 407-410
94 Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S, de la Chapelle A (1999)
Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity
to erythropoietin in the heterozygous state.
Blood
94: 2530-2532
95 Arcasoy MO, Karayal AF, Segal HM, Sinning JG, Forget BG (2002) A novel mutation in the ery-
thropoietin receptor gene is associated with familial erythrocytosis.
Blood
99: 3066-3069
96 Tavian M, Cortes F, Robin C, Schiavon V, Hallais MF, Coulombel L, Charbord P, Labastie MC,
Peault B (2000) The hemangioblast, common precursor of endothelial and hematopoietic cells.
Transfus Clin Biol
7: 238-241
97 Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M (1990) Erythropoietin has a mito-
genic and positive chemotactic effect on endothelial cells.
Proc Natl Acad Sci USA
87:
5978-5982
98 Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT (1994)
Erythropoietin receptor mRNA expression in human endothelial cells.
Proc Natl Acad Sci USA
91: 3974-3978
99 Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M (1993) Recombinant human ery-
thropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.
Kidney Int
43:
1010-1014
100 Carlini RG, Reyes AA, Rothstein M (1995) Recombinant human erythropoietin stimulates angio-
genesis
in vitro
.
Kidney Int
47: 740-745
101 Vogel V, Kramer HJ, Backer A, Meyer-Lehnert H, Jelkmann W, Fandrey J (1995) Effects of ery-
thropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular
endothelial cells.
Am J Hypertens
10: 289-296
102 Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F
(1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells
and stimulates neovascularization
in vivo
.
Blood
93: 2627-2636
103 Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y (1996) Brain capil-
lary endothelial cells express two forms of erythropoietin receptor mRNA.
Eur J Biochem
239:
494-500
104 Nagao M, Matsumoto S, Masuda S, Sasaki R (1993) Effect of tunicamycin treatment on ligand
binding to the erythropoietin receptor: conversion from two classes of binding sites to a single
class.
Blood
81: 2503-2510
105 Sensebe L, Deschaseaux M, Li J, Herve P, Charbord P (1997) The broad spectrum of cytokine
gene expression by myoid cells from the human marrow microenvironment.
Stem Cells
15:
133-143
106 Dame C, Fahnenstich H, Freitag P, Hofmann D, Abdul-Nour T, Bartmann P, Fandrey J (1998)
Erythropoietin mRNA expression in human fetal and neonatal tissue.
Blood
92: 3218-3225
107 Pelletier L, Regnard J, Fellmann D, Charbord P (2000) An
in vitro
model for the study of human
bone marrow angiogenesis: role of hematopoietic cytokines.
Lab Invest
80: 501-511
108 Heidenreich S, Rahn KH, Zidek W (1991) Direct vasopressor effect of recombinant human ery-
thropoietin on renal resistance vessels.
Kidney Int
39:259-265
109 Ammarguellat F, Gogusev J, Drueke TB (1996) Direct effect of erythropoietin on rat vascular
smooth-muscle cell via a putative erythropoietin receptor.
Nephrol Dial Transplant
11: 687-692
110 Buemi M, Allegra A, Aloisi C, Corica F, Frisina N (1999) Hemodynamic effects of recombinant
human erythropoietin.
Nephron
81: 1-4
111 Squadrito F, Altavilla D, Squadrito G, Campo GM, Arlotta M, Quartarone C, Saitta A, Caputi AP
(1999) Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunc-
tion in splanchnic artery occlusion shock.
Brit J Pharmacol
127: 482-488